News

HealthDay on MSN7m
Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
Key Takeaways Eli Lilly will acquire Verve for roughly $1 billionVerve is developing a one-time gene-editing treatment for ...
PMLive50m
Eli Lilly to expand cardiovascular disease pipeline with $1.3bn Verve acquisition
Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...
Asian shares are mixed and oil prices rise as escalating Iran-Israel crisis hits Wall Street
Asian shares are mixed and oil prices have advanced after the escalation of conflict in the Middle East hit Wall Street.
Opinion
Dow Jones Top Company Headlines at 7 AM ET: It's Time for UnitedHealth to Get Transparent With Its Accounting. But Will It? | The ...
Streaming Finally Outpaces Traditional TV. The Leading Platform Might Surprise You. YouTube represented 12.5% of all television viewing in May-the highest share of TV for any streamer to date. The new ...
Scholar Rock lead asset causes higher quality weight loss with Lilly’s obesity drug
Scholar Rock (NASDAQ:SRRK) announced Wednesday that its lead candidate, apitegromab, in combination with Eli Lilly’s ...
BioPharma Dive15m
A startup banks $66M to pursue ‘inclusive precision medicine’
With backers such as Regeneron’s venture arm, Actio Biosciences is working on medicines that counter a wide range of ...
Naharnet28m
Global shares gain, oil prices slip as markets eye Mideast conflict, await Fed's decision
Global shares were mostly higher Wednesday and oil prices slipped as investors awaited a decision on interest rates by the ...